Literature DB >> 2575913

Severe clinical manifestations of primary HIV infection.

B Tindall1, M Hing, P Edwards, T Barnes, A Mackie, D A Cooper.   

Abstract

Three cases of oesophageal candidiasis in association with primary HIV infection are described. In each case the candidiasis was associated with a decreased number of circulating CD4+ cells and responded well to treatment with ketoconazole. Clinicians should be aware that severe opportunistic infections may develop during this stage of infection, presumably as a result of transient immunodeficiency. We argue that the definition of primary HIV infection should be extended to include severe opportunistic infections and neurologic presentations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575913     DOI: 10.1097/00002030-198911000-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  Immediate immunosuppression caused by acute HIV-1 infection: a fulminant multisystemic disease 2 days post infection.

Authors:  P Ben-Galim; Y Shaked; A Vonsover; M Garty
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

2.  Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers.

Authors:  G H Mientjes; E J van Ameijden; H M Weigel; J A van den Hoek; R A Coutinho
Journal:  BMJ       Date:  1993-02-06

3.  Never too early for the opportunists!

Authors:  Anup Subedee; William Kimmel; Anthony A Donato
Journal:  BMJ Case Rep       Date:  2013-06-16

4.  A case of primary HIV type 1 and cytomegalovirus coinfection presenting with widespread clinical disease.

Authors:  Joseph Y Kim; Elyse J Singer; Laura Bonelli; Jeffrey D Klausner
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-01-29

5.  High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.

Authors:  Jörg Schüpbach; Leslie R Bisset; Stephan Regenass; Philippe Bürgisser; Meri Gorgievski; Ingrid Steffen; Corinne Andreutti; Gladys Martinetti; Cyril Shah; Sabine Yerly; Thomas Klimkait; Martin Gebhardt; Franziska Schöni-Affolter; Martin Rickenbach; J Barth; M Battegay; E Bernascon; J Böni; H C Bucher; P Bürgisser; C Burton-Jeangros; A Calmy; M Cavassini; R Dubs; M Egger; L Elzi; J Fehr; M Fischer; M Flepp; P Francioli; H Furrer; C A Fux; M Gorgievski; H Günthard; B Hasse; H H Hirsch; B Hirschel; I Hösli; C Kahlert; L Kaiser; O Keiser; C Kind; T Klimkait; H Kovari; B Ledergerber; G Martinetti; B Martinez de Tejada; N Müller; D Nadal; G Pantaleo; A Rauch; S Regenass; M Rickenbach; C Rudin; P Schmid; D Schultze; F Schöni-Affolter; J Schüpbach; R Speck; P Taffé; A Telenti; A Trkola; P Vernazza; V von Wyl; R Weber; S Yerly
Journal:  BMC Infect Dis       Date:  2011-09-26       Impact factor: 3.090

6.  Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.

Authors:  Jörg Schüpbach; Leslie R Bisset; Martin D Gebhardt; Stephan Regenass; Philippe Bürgisser; Meri Gorgievski; Thomas Klimkait; Corinne Andreutti; Gladys Martinetti; Christoph Niederhauser; Sabine Yerly; Stefan Pfister; Detlev Schultze; Marcel Brandenberger; Franziska Schöni-Affolter; Alexandra U Scherrer; Huldrych F Günthard
Journal:  BMC Infect Dis       Date:  2012-04-12       Impact factor: 3.090

7.  Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.

Authors:  Jörg Schüpbach; Martin D Gebhardt; Zuzana Tomasik; Christoph Niederhauser; Sabine Yerly; Philippe Bürgisser; Lukas Matter; Meri Gorgievski; Rolf Dubs; Detlev Schultze; Ingrid Steffen; Corinne Andreutti; Gladys Martinetti; Bruno Güntert; Roger Staub; Synove Daneel; Pietro Vernazza
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.